$VIR planning two more P2-HBV trials this year...VIR-2218 in China and VIR-2218 + pegIFNa. PegIFNa, yuck! Why use interferon? Is use of $ALNY RNAi tech not producing good enough results as $JNJ + $ARWR assumptive are, as they have no need for IFN? Maybe VIR will address this.